Company / Current Assets
Phathom Pharmaceuticals, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$229.0M
FY2025
5-year range
$160.5M / $397.4M
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
#184 of 213
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s current assets of $229M is lower than 86% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 8 years, ranging from $902,000 in FY2018 to $397M in FY2023.
Based on SEC 10-K filings.
$229M in FY2025 with a 5-year CAGR of -4.7%.
Declined from $397M to $229M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- -4.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 213This company $229.0M Sector average $2.5B
▼
-90.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.7%, indicating a declining trend.
- In FY2025, current assets decreased 36.4% year-over-year.
- Ranks #184 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $229.0M | -36.4% |
| FY2024 | $360.1M | -9.4% |
| FY2023 | $397.4M | +147.6% |
| FY2022 | $160.5M | -13.9% |
| FY2021 | $186.5M | -36.0% |
| FY2020 | $291.4M | +14.0% |
| FY2019 | $255.6M | +28237.1% |
| FY2018 | $902.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026